ClinicalTrials.Veeva

Menu

The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue

Yale University logo

Yale University

Status and phase

Completed
Early Phase 1

Conditions

Brown Adipose Tissue

Treatments

Radiation: PET imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT02038595
1008007284

Details and patient eligibility

About

This study seeks to assess a novel imaging technique to image brown adipose tissue utilizing the norepinephrine transporter.

Enrollment

10 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 18-30 yrs
  • BMI < 24 kg/m2
  • Caucasian

Exclusion criteria

  • Current neuro-psychiatric illness
  • substance abuse
  • medical or neurological illnesses likely to affect physiology or anatomy, i.e., uncontrolled hypertension, cardiovascular disorders
  • current pregnancy
  • current breast feeding
  • suicidal ideation or behavior
  • use of medications which potentially affect NET binding within 2 weeks of the PET scans.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Healthy subjects
Experimental group
Description:
Healthy subjects (male, female)
Treatment:
Radiation: PET imaging

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems